Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04805840 · ClinicalTrials.gov registry record
Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 93
- Enrollment target
NCT04805840 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 93 participants.
The verdict
NCT04805840 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 93 participants
- Enrollment target
Study Summary
This study aims to assess how an at-home COVID-19 frequent testing regimen using the CoV-SCAN test kit and a paired phone application to help interpret the test result compares to once-a-week or three-times-a-week polymerase chain reaction (PCR) (molecular) testing to identify a SARS-CoV-2 infection. Employees and cast members at Media and Entertainment Company and its affiliates will be recruited to test whether frequent use of CoV-SCAN will perform as well or better than weekly molecular testing and at least as well as three-times-a-week molecular testing.
Interventions
- DEVICE CoV-SCAN rapid COVID-19 antigen test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2021-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04805840
The ClinicalTrials.gov registry entry for NCT04805840 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CoV-SCAN rapid COVID-19 antigen test is the first listed.
NCT04805840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04805840 about?
NCT04805840 is a clinical study titled "Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen". This study aims to assess how an at-home COVID-19 frequent testing regimen using the CoV-SCAN test kit and a paired phone application to help interpret the test result compares to once-a-week or three-times-a-week polymerase chain reaction (PCR) (molecular) testing to identify a SARS-CoV-2 infection...
What is the current status of trial NCT04805840?
This trial is currently terminated. The enrollment target is 93 participants. The study started on 2021-02-19. Estimated completion is 2021-07-14.
What interventions are being tested in trial NCT04805840?
The interventions under investigation include: CoV-SCAN rapid COVID-19 antigen test (DEVICE).
Who is sponsoring clinical trial NCT04805840?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.